TREM2 and Alzheimer disease: However, a separate large-scale analysis, including neuropathologically confirmed AD cases, found that a subset of individuals carrying only the TREM2 R47H variant—without APOE4—also develop AD pathology [111], indicating that TREM2 R47H alone may be sufficient to drive disease progression in some cases.